Nondiabetic Consequences of Obesity on Kidney

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2006 Feb 24

PMID 16491417

Citations 30

Authors

Tarak Srivastava

Affiliations

Soon will be listed here.

Abstract

There has been a major increase in obesity among children over the past twenty years. Obesity is associated with glomerular hyperperfusion and hyperfiltration from physiological (mal)adaptation resulting from afferent arteriolar vasodilatation. The renal injury from hyperfiltration in obesity is further exacerbated by concomitant presence of dyslipidemia, hyperglycemia and/or insulin resistance, inflammation and hypertension. The renal injury clinically manifests as microalbuminuria, proteinuria and/or poor renal function, and is histologically characterized by glomerulomegaly, mesangial expansion and/or sclerosis, which has been termed "obesity related glomerulopathy". Obesity portends a poor prognosis in subjects with chronic kidney diseases, IgA nephropathy and nephrectomy. Obese individuals on dialysis and renal transplant have mixed outcomes. The purpose of this review is to highlight the nondiabetic consequences of obesity on kidney for the pediatric nephrology community as we begin to address the obesity epidemic in children.

Citing Articles

Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats.

Ekperikpe U, Mandal S, Holt S, Daniels J, Johnson T, Cooper J Am J Physiol Renal Physiol. 2023; 325(3):F363-F376.

PMID: 37498548 PMC: 10639024. DOI: 10.1152/ajprenal.00078.2023.

Chronic treatment with IL-25 increases renal M2 macrophages and reduces renal injury in obese Dahl salt-sensitive rats during the prepubescent stage.

Poudel B, Ekperikpe U, Mandal S, Wilson G, Shields C, Cornelius D Am J Physiol Renal Physiol. 2023; 325(1):F87-F98.

PMID: 37167270 PMC: 10292980. DOI: 10.1152/ajprenal.00209.2022.

Neutralizing MIP3 Reduces Renal Immune Cell Infiltration and Progressive Renal Injury in Young Obese Dahl Salt-Sensitive Rats.

Ekperikpe U, Poudel B, Shields C, Mandal S, Cornelius D, Williams J J Pharmacol Exp Ther. 2022; 384(3):445-454.

PMID: 36507846 PMC: 9976792. DOI: 10.1124/jpet.122.001298.

Glomerular hyperfiltration: part 2-clinical significance in children.

Adebayo O, Nkoy A, Van den Heuvel L, Labarque V, Levtchenko E, Delanaye P Pediatr Nephrol. 2022; 38(8):2529-2547.

PMID: 36472656 DOI: 10.1007/s00467-022-05826-5.

Body Composition and Cardiovascular Risk Factors in a Paediatric Population.

Golob Jancic S, Mocnik M, Svigelj M, Marcun Varda N Children (Basel). 2022; 9(5).

PMID: 35626780 PMC: 9139520. DOI: 10.3390/children9050603.

References

Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S . Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004; 65(5):1870-6. DOI: 10.1111/j.1523-1755.2004.00582.x. View

Shek E, Brands M, Hall J . Chronic leptin infusion increases arterial pressure. Hypertension. 1998; 31(1 Pt 2):409-14. DOI: 10.1161/01.hyp.31.1.409. View

Abbott K, Glanton C, Trespalacios F, Oliver D, Ortiz M, Agodoa L . Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int. 2004; 65(2):597-605. DOI: 10.1111/j.1523-1755.2004.00385.x. View

Praga M, Hernandez E, Herrero J, Morales E, Revilla Y, Diaz-Gonzalez R . Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000; 58(5):2111-8. DOI: 10.1111/j.1523-1755.2000.00384.x. View

McDonald S, Collins J, Rumpsfeld M, Johnson D . Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int. 2004; 24(4):340-6. View

Wolf G, Hamann A, Han D, Helmchen U, Thaiss F, Ziyadeh F . Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]. Kidney Int. 1999; 56(3):860-72. DOI: 10.1046/j.1523-1755.1999.00626.x. View

Wofford M, Anderson Jr D, Brown C, Jones D, Miller M, Hall J . Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens. 2001; 14(7 Pt 1):694-8. DOI: 10.1016/s0895-7061(01)01293-6. View

Ogden C, Flegal K, Carroll M, Johnson C . Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002; 288(14):1728-32. DOI: 10.1001/jama.288.14.1728. View

Besbas N, Ozaltin F, Coskun T, Ozalp S, Saatci U, Bakkaloglu A . Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children. Pediatr Nephrol. 2003; 18(12):1255-9. DOI: 10.1007/s00467-003-1264-4. View

10.

Freedman D, Srinivasan S, Valdez R, Williamson D, Berenson G . Secular increases in relative weight and adiposity among children over two decades: the Bogalusa Heart Study. Pediatrics. 1997; 99(3):420-6. DOI: 10.1542/peds.99.3.420. View

11.

Yoshioka T, Mitarai T, Kon V, Deen W, Rennke H, Ichikawa I . Role for angiotensin II in an overt functional proteinuria. Kidney Int. 1986; 30(4):538-45. DOI: 10.1038/ki.1986.219. View

12.

Praga M, Hernandez E, Morales E, Campos A, Valero M, Martinez M . Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001; 16(9):1790-8. DOI: 10.1093/ndt/16.9.1790. View

13.

Ziyadeh F, Hoffman B, Han D, Iglesias-de la Cruz M, Hong S, Isono M . Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A. 2000; 97(14):8015-20. PMC: 16662. DOI: 10.1073/pnas.120055097. View

14.

Festa A, DAgostino Jr R, Howard G, Mykkanen L, Tracy R, Haffner S . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102(1):42-7. DOI: 10.1161/01.cir.102.1.42. View

15.

Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H . Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000; 105(9):1243-52. PMC: 315441. DOI: 10.1172/JCI8341. View

16.

de Jong P, Verhave J, Pinto-Sietsma S, Hillege H . Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002; 26 Suppl 4:S21-4. DOI: 10.1038/sj.ijo.0802213. View

17.

Must A, Jacques P, Dallal G, BAJEMA C, Dietz W . Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992; 327(19):1350-5. DOI: 10.1056/NEJM199211053271904. View

18.

Bennett W, McEvoy K, Henell K, Valente J, Douzdjian V . Morbid obesity does not preclude successful renal transplantation. Clin Transplant. 2004; 18(1):89-93. View

19.

Considine R, Sinha M, Heiman M, Kriauciunas A, STEPHENS T, Nyce M . Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996; 334(5):292-5. DOI: 10.1056/NEJM199602013340503. View

20.

Mak R, Cheung W, Cone R, Marks D . Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol. 2005; 20(3):427-31. DOI: 10.1007/s00467-004-1789-1. View